Sue Lowe
Optometrist · Laramie, WYNPI 1083686331
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (59.3%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Johnson & Johnson Vision Care, Inc. accounts for 78.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $918, more than ten times the $66 reported in 2019.
Across 19 payments — averaging $61.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$918
- Coopervision Inc.$91
- Novartis$75
- Shire North American Group Inc$66
- Carl Zeiss Meditec AG$19
What the payments were for
- Travel & lodging$69259%
- Food & beverage$45739%
- Gifts$192%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 10 | $918 |
| Coopervision Inc. | 1 | $91 |
| Novartis | 4 | $75 |
| Shire North American Group Inc | 3 | $66 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$673
How this compares
$1,168 in reported general payments places this provider in the 85th percentile of 102 optometrist providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 59 | $24,005 |
| RestasisCyclosporine | 29 | $21,423 |
| XiidraLifitegrast | 12 | $7,982 |
| Brimonidine Tartrate | 45 | $5,217 |
| Travoprost | 15 | $2,353 |
| Timolol Maleate | 43 | $1,581 |
| Latanoprost | 175 | $1,450 |
| Fluorometholone | 15 | $901 |
| Prednisolone Acetate | 15 | $627 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 11 | $464 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 27 | $366 |
| ErythromycinErythromycin Base | 45 | $280 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $161 |
| Dorzolamide Hcl | 15 | $151 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Laramie
- Michelle ChaneyLaramie$4K
- Garrett HowellLaramie$469
- Nikalous TolmanLaramie$246
- Gary PoteetLaramie$213
- Brian PieperLaramie$207
- Mark WellsCheyenne$251K
- David EldredCheyenne$177K
- Joseph MunsellCheyenne$5K
- Jason WhitmanCasper$4K
- Shelby ZemskiCheyenne$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.